We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 226

Recent developments in biosimilars: Canada, EU, France and the U.S.
  • Norton Rose Fulbright Canada LLP
  • USA, Canada, European Union, France
  • January 29 2014

There have been a number of developments in biosimilars of late, including regulatory approvals in Canada issued on January 15, 2014 for two


Kathleen Barry
  • Winston & Strawn LLP

Brian D. Fergemann
  • Winston & Strawn LLP

Michael L. Brody
  • Winston & Strawn LLP

James Hurst
  • Winston & Strawn LLP

Allan Fanucci
  • Winston & Strawn LLP

Cori Annapolen Goldberg
  • Norton Rose Fulbright

Sophie Pelé
  • Norton Rose Fulbright

Stewart A. Baker
  • Steptoe & Johnson LLP

Adrienne M. Blanchard
  • Norton Rose Fulbright